Data / Form D filings / Purigen Biosystems, Inc.
Purigen Biosystems, Inc.: Form D filings
Purigen Biosystems, Inc., a biotechnology company in Pleasanton, CA, filed 6 Form D notices with the SEC between 2013 and 2021. The latest, on April 6, 2021, reports $34.4 million sold of a $34.4 million offering to 16 investors.
Find out what Purigen Biosystems, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5700 Stoneridge Dr., Ste. 100, Pleasanton, CA, 94588
- Phone
- (925) 264-1364
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574680
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 6, 2021 | New notice | $34,444,759 | $34,444,759 | $0 | 16 | Mar 22, 2019 | sec.gov |
| Jun 4, 2018 | Amendment | $30,828,000 | $26,448,000 | $4,380,000 | 28 | Mar 4, 2016 | sec.gov |
| Oct 24, 2017 | Amendment | $28,022,652 | $20,849,609 | $7,173,043 | 28 | Mar 4, 2016 | sec.gov |
| Mar 10, 2016 | New notice | $21,110,615 | $13,011,856 | $8,098,759 | 27 | Mar 4, 2016 | sec.gov |
| Aug 1, 2014 | New notice | $1,700,000 | $200,000 | $1,500,000 | 5 | Jul 21, 2014 | sec.gov |
| Apr 19, 2013 | New notice | $3,000,000 | $830,000 | $2,170,000 | 13 | Apr 10, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Barney E. Saunders,Ph.D. | Executive Officer, Director | |
| Steve E. Reichenbach | Executive Officer | |
| Bill W. Colston, Ph.D. | Director | |
| Mira E. Chaurushiya, Ph.D. | Director | |
| Kevin W. Corcoran | Director | |
| Klint E. Rose, Ph.D. | Executive Officer | |
| Joseph J. Victor | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Apr 5, 2021 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Purigen Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.